➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Medtronic
Johnson and Johnson
Moodys
Harvard Business School

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: indinavir sulfate

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

indinavir sulfate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Merck Sharp Dohme CRIXIVAN indinavir sulfate CAPSULE;ORAL 020685 NDA Merck Sharp & Dohme Corp. 0006-0571-43 360 CAPSULE in 1 BOTTLE (0006-0571-43)
Merck Sharp Dohme CRIXIVAN indinavir sulfate CAPSULE;ORAL 020685 NDA Merck Sharp & Dohme Corp. 0006-0573-62 180 CAPSULE in 1 BOTTLE (0006-0573-62)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Express Scripts
Merck
Medtronic
Baxter